Vcanbio Cell and Gene Engineering

Vcanbio Cell & Gene Engineering is a prominent Chinese biotechnology firm focused on the dual-core business of cell therapy and gene technology. The company operates an extensive network of stem cell banks across China, providing storage services for cord blood, umbilical cord, and adipose tissue. Beyond storage, Vcanbio is a major player in precision medicine, offering genetic testing, diagnostic reagents, and developing a robust pipeline of regenerative medicine products, including mesenchymal stem cell therapies for liver and autoimmune diseases. Through its acquisition of US-based OriGene Technologies and strategic investments in firms like Juventas Cell Therapy, Vcanbio has established a global footprint in life science research tools and advanced oncology treatments.